Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Santhera Pharmaceuticals Holding AG · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $197.20M | $197.20M - $197.20M | -$2.24M | $4.621 | 1 |
| Dec 2029 | $189.97M | $189.97M - $189.97M | -$2.16M | $3.014 | 1 |
| Dec 2028 | $134.97M | $134.97M - $134.97M | -$1.53M | $0.623 | 1 |
| Dec 2027 | $114.93M | $114.93M - $114.93M | -$1.31M | $0.023 | 1 |
| Dec 2026 | $93.03M | $93.03M - $93.03M | -$1.06M | -$1.239 | 1 |
| Dec 2025 | $77.40M | $77.40M - $77.40M | -$879.2K | -$2.206 | 1 |
| Dec 2024 | $31.93M | $31.93M - $31.93M | -$362.8K | -$2.204 | 1 |
| Dec 2023 | $7.59M | $7.59M - $7.59M | -$972.3K | -$2.21 | 1 |
| Dec 2021 | $5.87M | $5.87M - $5.87M | -$751.7K | -$16.832 | 1 |
| Dec 2020 | $16.97M | $16.97M - $16.97M | -$2.17M | -$42.254 | 1 |
| Dec 2019 | $79.52M | $79.52M - $79.52M | -$10.19M | $0.405 | 1 |
| Dec 2018 | $32.46M | $32.46M - $32.46M | -$4.16M | -$68.213 | 1 |